03:43 AM EST, 11/25/2025 (MT Newswires) -- Neil Kumar, Director, Chief Executive Officer, on November 20, 2025, sold 26,156 shares in BridgeBio Pharma ( BBIO ) for $1,722,224. Following the Form 4 filing with the SEC, Kumar has control over a total of 5,622,909 common shares of the company, with 228,776 shares held directly and 5,394,133 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000147083125000366/xslF345X05/wk-form4_1764027999.xml